Patents by Inventor Ronald Buggage

Ronald Buggage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA STRUCTURE FOR TREATING OCULAR PATHOLOGIES
    Publication number: 20240189448
    Abstract: The present invention mainly relates to a DNA structure for use in treating an ocular pathology and for the non-viral transfer of nucleic acids into the muscular cells of the eyeball of a patient suffering from the ocular pathology; characterised in that it particularly comprises a first sequence encoding a first therapeutic protein and a second sequence encoding a second therapeutic protein which is different from the first therapeutic protein, the DNA structure being administered to the patient by injection into a ciliary muscle then electrotransfer into the cells of the ciliary muscle.
    Type: Application
    Filed: June 30, 2021
    Publication date: June 13, 2024
    Inventors: Thierry BORDET, Elise ORHAN, Karine BIGOT, Ronald BUGGAGE
  • COMPOSITIONS COMPRISING IL6R ANTIBODIES FOR THE TREATMENT OF UVEITIS AND MACULAR EDEMA AND METHODS OF USING SAME
    Publication number: 20210301027
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: February 24, 2021
    Publication date: September 30, 2021
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti
  • Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
    Patent number: 10968278
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: April 6, 2021
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti
  • COMPOSITIONS COMPRISING IL6R ANTIBODIES FOR THE TREATMENT OF UVEITIS AND MACULAR EDEMA AND METHODS OF USING SAME
    Publication number: 20170166646
    Abstract: The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
    Type: Application
    Filed: November 3, 2016
    Publication date: June 15, 2017
    Inventors: Preethi Aavali Sridhara Sundaram, Ronald Buggage, Karen W. Chu, Valérie Corp dit Genti, Kristine A. Erickson, Dominique Mery-Mignard, Rafael Varona, Robert L. Vitti